Legend Biotech Corp. (LEGN)
20.94
-0.88
(-4.03%)
USD |
NASDAQ |
Aug 24, 16:00
21.31
+0.37
(+1.77%)
After-Hours: 20:00
Legend Biotech Total Assets (Quarterly) : 1.751B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.751B |
| March 31, 2026 | 1.597B |
| December 31, 2025 | 1.734B |
| September 30, 2025 | 1.713B |
| June 30, 2025 | 1.690B |
| March 31, 2025 | 1.616B |
| December 31, 2024 | 1.670B |
| September 30, 2024 | 1.736B |
| June 30, 2024 | 1.798B |
| March 31, 2024 | 1.775B |
| December 31, 2023 | 1.849B |
| September 30, 2023 | 1.839B |
| June 30, 2023 | 1.931B |
| March 31, 2023 | 1.209B |
| Date | Value |
|---|---|
| December 31, 2022 | 1.331B |
| September 30, 2022 | |
| June 30, 2022 | 1.023B |
| March 31, 2022 | 1.044B |
| December 31, 2021 | 1.119B |
| September 30, 2021 | 813.76M |
| June 30, 2021 | 875.12M |
| March 31, 2021 | 615.27M |
| December 31, 2020 | 722.09M |
| September 30, 2020 | 708.64M |
| June 30, 2020 | 772.86M |
| March 31, 2020 | 364.94M |
| December 31, 2019 | 287.72M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| AbbVie, Inc. | 135.12B |
| Dianthus Therapeutics, Inc. | 1.213B |
| Gilead Sciences, Inc. | 49.36B |
| Ironwood Pharmaceuticals, Inc. | 285.13M |
| Arbutus Biopharma Corp. | 274.02M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 521.32M |
| Shareholders Equity (Quarterly) | 1.230B |
| Debt to Equity Ratio | 0.2263 |
| Current Ratio | 3.041 |
| Net Debt Paydown Yield | 0.30% |